The Trop-2-targeting antibody drug conjugate DB-1305 has higher anti-tumor activity and a potentially better safety profile compared with DS-1062-MedSci.cn

The Trop-2-targeting antibody drug conjugate DB-1305 has higher anti-tumor activity and a potentially better safety profile compared with DS-1062

Zhang, Y; Li, B; Shi, R; Qiu, Y; Zhong, C

EUROPEAN JOURNAL OF CANCER, 2022; 174 (): S91

科室
- - 订阅+
  - 更多科室
工具
服务